Professor Cesaltina Lorenzoni, MD, MSC, PhD, is a Medical Pathologist, Head of the National Cancer Control Programme at the Ministry of Health in Mozambique, and the Scientific and Pedagogical Director at Maputo Central Hospital. She is an Assistant Professor at the Faculty of Medicine of Eduardo Mondlane University.

She is Adjunt Professor at Rice University (USA), and a visiting professor at the University of Barcelona (Spain), and Guest Speaker at MD Anderson Cancer Center - University of Texas (USA).

Dr. Lorenzoni is the President of the African Organisation for Research & Training in Cancer (AORTIC) for the 2025-2027 term.

She served as President-Elect of the African Organisation for Research & Training in Cancer (AORTIC) for the 2023-2025 term.

Dr. Lorenzoni obtained her medical degree from the Faculty of Medicine of Eduardo Mondlane University and specialized in Anatomical Pathology at Maputo Central Hospital. She holds a Master of Public Health (MPH) from the same university, with a thesis focused on Cancer Epidemiology, and a Master of Science (MSc) in Health Policy and Programme Planning.

She completed her PhD in International Health with a focus on Translational Cancer Epidemiology at the University of Barcelona, Spain.

Dr. Lorenzoni has published more than 80 peer-reviewed articles and is the author of three book chapters published by the African Cancer Registry Network (AFCRN), the International Agency for Research on Cancer (IARC), the World Health Organization (WHO), and the Union for International Cancer Control (UICC). She is the author and co-author of various national manuals and standards, such as, the Standard Procedure Manual for Population-Based Cancer Registries in Sub Saharan Africa - for Portuguese-speaking countries published by AFCRN, the Investment Case for Cancer in Mozambique, published by WHO and the National Cancer Control Plan of Mozambique (2019-2029), published by Ministry of Health of Mozambique.

She serves as Principal Investigator (PI) in several research projects in partnership with national and international institutions, of the following research projects:

1. The Center for Innovation and Translation of Point-of-Care Technologies for Equitable Cancer Care (CITEC).
2. Sample-to-answer HPV DNA nucleic acid test for cervical cancer screening in Mozambique (Natflow).
3. The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable
technologies for the prevention and diagnosis of cervical cancer in women living with HIV.
4. Phil Study: A Randomized Clinical Trial to Assess the Effectiveness of Thermal Ablation versus Loop
Electrosurgical Excision Procedure (LEEP) for Cervical Cancer Risk Reduction in HIV+ Women living in
Mozambique
5. Integrating HPV-DNA Testing Into HIV Care: Results Of A Programatic Implementation In Four Health Facilities
In Maputo City, Mozambique
6. Population-based cancer registries in Maputo City - Mozambique.
7. The ECHO Project as a tool to support healthcare providers in Mozambique in cervical cancer screening
through telementoring.
8. Cervical cancer prevention through the development and use of low-cost HPV detection methods and new
technologies for diagnosing pre-invasive cervical disease.
9. A training programme for Obstetrics and Gynaecology residents in the diagnosis and treatment of women
with pre-invasive cervical disease — strengthening clinical skills in colposcopy, LEEP, and classroom-based
training at Maputo Central Hospital.
10. The journey of women with breast cancer in Mozambique: what is the best path? an intervention to reduce
inequalities in breast cancer treatment.
11. Evaluating innovative technologies and approaches to addressing cervical cancer in the republic of
Mozambique.
12. Assessment of New HPV Test Using Banked HPV Samples in Mozambique.
13. Cervical Cancer Screening using Primary Human Papillomavirus (HPV) in Mozambique.
14. Low-Cost Mobile Colposcopy and Confocal Imaging for Global Prevention of Cervical Cancer

She served as Chair of the Education and Training Committee of AORTIC from 2022 to 2023 and represented Portuguese-speaking African countries (PALOP) from 2020 to 2021.

Dr. Lorenzoni is a member of the Scientific Review Committee of the American Association for Cancer Research(AACR) and the U.S. National Cancer Institute (NCI) for the BIG Cat Early-Career Investigator Catalytic Grants Programme.
She is also a member of the African Cancer Registry Network (AFCRN) and the Director of the Maputo City
PopulationBased Cancer Registry.

In September 2022, she received the International Gynaecologic Cancer Society (IGCS) Award, in the category of Community Advancement in Low-Resource Settings, in New York, USA.
In June 2024, she received the Global Leader in Health Award from the Global Health Catalyst (GHC) in Washington, USA.

She served as President of the Cancer Association of Mozambique from 2013 to July 2022 and she currently the President of the chair Assembly of this organisation since 2023.

She designed and founded in 2024 the first Clinical Research and Training Centre at Maputo Central Hospital, focused on developing clinical trials in the field of cancer.